UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Cancer and metastasis reviews, 2016-12, Vol.35 (4), p.575-588

2016

Volltextzugriff (PDF)

Protein localization in disease and therapy

Journal of cell science, 2011-10, Vol.124 (Pt 20), p.3381-3392

2011

Volltextzugriff (PDF)

Mechanisms Controlling PD-L1 Expression in Cancer

Molecular cell, 2019-11, Vol.76 (3), p.359-370

2019

Volltextzugriff (PDF)

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Nature communications, 2021-02, Vol.12 (1), p.832-17, Article 832

2021

Volltextzugriff (PDF)

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Clinical cancer research, 2017-07, Vol.23 (14), p.3711-3720

2017

Volltextzugriff (PDF)

Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth

Cell research, 2018-08, Vol.28 (8), p.862-864

2018

Volltextzugriff (PDF)

Regulation and Role of EZH2 in Cancer

Cancer Research and Treatment, 2014, 46(3), , pp.209-222

2014

Volltextzugriff (PDF)

Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases

The FEBS journal, 2015-10, Vol.282 (19), p.3693-3721

2015

Volltextzugriff (PDF)

Palmitoylation stabilizes PD-L1 to promote breast tumor growth

Cell research, 2019-01, Vol.29 (1), p.83-86

2019

Volltextzugriff (PDF)

TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

The Journal of clinical investigation, 2021-04, Vol.131 (8), p.1-13

2021

Volltextzugriff (PDF)

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer

Oncogene, 2021-08, Vol.40 (31), p.4992-5001

2021

Volltextzugriff (PDF)

The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells

Immunity (Cambridge, Mass.), 2018-09, Vol.49 (3), p.504-514.e4

2018

Volltextzugriff (PDF)

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

Cancer cell, 2019-08, Vol.36 (2), p.168-178.e4

2019

Volltextzugriff (PDF)

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Molecular cell, 2018-08, Vol.71 (4), p.606-620.e7

2018

Volltextzugriff (PDF)

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Nature communications, 2021-12, Vol.12 (1), p.7041-7041, Article 7041

2021

Volltextzugriff (PDF)

Deubiquitination and Stabilization of PD-L1 by CSN5

Cancer cell, 2016-12, Vol.30 (6), p.925-939

2016

Volltextzugriff (PDF)

lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals

Cell, 2014-11, Vol.159 (5), p.1110-1125

2014

Volltextzugriff (PDF)

Actin cytoskeleton remodeling drives epithelial‐mesenchymal transition for hepatoma invasion and metastasis in mice

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2226-2243

2018

Volltextzugriff (PDF)

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

The Journal of clinical investigation, 2019-08, Vol.129 (8), p.3324-3338

2019

Volltextzugriff (PDF)

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Cancer cell, 2018-02, Vol.33 (2), p.187-201.e10

2018

Volltextzugriff (PDF)

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Nature communications, 2016-08, Vol.7 (1), p.12632-11, Article 12632

2016

Volltextzugriff (PDF)

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

Journal of biomedical science, 2020-07, Vol.27 (1), p.77-77, Article 77

2020

Volltextzugriff (PDF)

TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer

Modern pathology, 2021-04, Vol.34 (4), p.710-719

2021

Volltextzugriff (PDF)

A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer

Clinical cancer research, 2009-02, Vol.15 (3), p.752-757

2009

Volltextzugriff (PDF)

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

Cancer cell, 2013-03, Vol.23 (3), p.316-331

2013

Volltextzugriff (PDF)

1 – 25 von 984

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(825)

Publikationsform

Sprache

Englisch
(984)
Japanisch
(166)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Protein localization in disease and therapy

Mechanisms Controlling PD-L1 Expression in Cancer

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth

Regulation and Role of EZH2 in Cancer

Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases

Palmitoylation stabilizes PD-L1 to promote breast tumor growth

TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer

The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Deubiquitination and Stabilization of PD-L1 by CSN5

lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals

Actin cytoskeleton remodeling drives epithelial‐mesenchymal transition for hepatoma invasion and metastasis in mice

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer

A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

Aktive Filter

Suchergebnisse filtern